Create an Account - Increase your productivity, customize your experience, and engage in information you care about.
For Immediate Release: April 13, 2021
Today, the Food and Drug Administration (FDA) and Center for Disease Control and Prevention (CDC) issued a statement regarding the Johnson & Johnson COVID-19 vaccine recommending a pause in its use out of an abundance of caution.
The Department of Public Health is notifying all Massachusetts providers to pause administration of the Johnson & Johnson COVID-19 vaccine, effective immediately.
“In response to today’s recommendation from the FDA and CDC to pause J&J vaccines due to an extremely rare condition reported in 6 individuals nationwide, the Department of Public Health directed all providers to immediately pause administration of the J&J vaccine until federal health experts investigate this matter. This action is being taken out of an abundance of caution as the FDA and CDC review these 6 cases, none of which are known to be linked to Massachusetts. The FDA has reported over 6.8M doses of J&J have been administered nationwide. Individuals who have received a J&J vaccine should contact their physician if they have concerns.” - Command Spokesperson